investor login

contact

team

dedicated funds

news

 portfolio

Ten63 Therapeutics is a computational drug discovery company leveraging its proprietary AI- and physics-based platform to design novel therapeutics for challenging, historically “undruggable” targets. By exploring vast chemical space with precision and speed, Ten63 aims to accelerate the creation of first- and best-in-class medicines.

Active, Bio Tech, HVP VII, Portfolio

back to portfolio

contact

© hatteras venture partners | all rights reserved | terms + privacy | site credit

 team

 portfolio

news

home

Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.

dedicated funds

contact

 team

dedicated funds

news

home

 portfolio